Print Page | Sign In | Join Today
Focus Around Virginia
Blog Home All Blogs
Search all posts for:   

 

View all (66) posts »
 

Show you the money

Posted By Administration, Tuesday, January 24, 2017
Updated: Monday, January 23, 2017

Dear Members and Friends,

 

Buckle your seat belts.

 

A top priority of Virginia Bio is to help Virginia companies and translational researchers access the private investment and non-dilutive capital they require to fuel innovation, develop products and services, create jobs. And we are off to the races!

 

Private Investment

On April 6 at our statewide conference THRiVE 2017 in Virginia Beach (think oceanfront hotel!) we’ll bring together many private sources of capital in Virginia.  We’ll have the teams from the new funds devoted to bioscience investment at Inova, UVA and Sentara’s Third Core.  Leaders of those funding sources will introduce themselves and present their goals and process, and be available for private meetings which can be arranged in advance.

  

Also that day at the Beach (think dolphins!), we’ll have other investors, like 757 Angels, Cav Angels, and VBHRC (the Catalyst), and we will be adding to the list in the coming weeks.   Come and meet these people and create relationships that will enable your future growth and success.   Register Now to Attend

 

Our April 6 THRiVE 2017 will be a further development of the fantastic Virginia Reception we just put on in San Francisco on Sunday evening January 8, the eve of the JPMorgan Health Care Conference week (JPM).  Despite the East Coast blizzard and the West Coast “River of Rain” over 175 investors and strategics joined Virginia companies and investors, to be introduced to Inova, UVA and Sentara leadership, feel the enthusiasm for the industry in Virginia, and make new contacts among our companies and universities.  Governor McAuliffe attended.

 

If you are a company or translational research institution which now or in the future needs private investment, I urge you to go to San Francisco next January during JPM week.  Really, consider it closely.  Perhaps you saw two weeks ago that Cavion, a Charlottesville-based clinical stage pharmaceutical company, closed a $26M Series A round.  CEO Andy Krouse reports that he met his lead investor, Lilly Ventures, at JPM two years ago - and indeed at our Virginia Reception!

 

To get a good look, take in our February 8 luncheon in Richmond reflecting on JP Morgan Health Care week.  Register to attend, or watch over the web by livestream.  Get in touch with me and I can put you in touch with others who did attend and can describe it to you.  Do it soon, because rooms and flights are already being taken for next year!

 

Non-dilutive federal funding for the biosciences

But we are not stopping there!  We are stepping up our efforts to help you become familiar with, understand and get strategic about accessing non-dilutive federal funding for the biosciences.  Big news here!

 

We have engaged Liz Powell, of G2G Consulting in NoVa, to provide special reports, calendars, updates, webinars and coaching to our members regarding federal funding for the biosciences.   Over the next three months she’ll lead a series of webinars, from basics to specific opportunities to how you create a strategic approach.   Register now for the first on Wednesday, January 25.

 

This too will build to something bigger and better at our April 6 THRiVE conference at the Beach (soft sand, lapping waves!).  Liz will lead a team offering a special bolt on workshop on “Going strategic in pursuit of federal funding” on Friday morning April 7, the day after the full day conference.

 

Also at the Conference, Thursday April 6 (your favorite beach beverage!), we’ll have an extraordinary group of leaders from the US Veterans Health Administration, US Military, DARPA and BARDA discuss current activities, unmet needs and upcoming opportunities in biomedical R&D.   So, companies, researchers, clinicians …. please join us, make new contacts, uncover new opportunities, and let’s make a public commitment to doing the best we can to help Healing our Heroes.

 

A terrific opportunity is at hand right now for bioscience companies trying to access relationships, funding and collaborations with the military.  A call for abstracts to participate in the 2017 Military Health System Research Symposium (MHSRS) has just issued.  This extraordinary joint symposium provides a collaborative environment for military medical care providers with deployment experience, DoD scientists, academia and industry to exchange information on research advancements and health care developments in the areas of Combat Casualty Care, Military Operational Medicine, Clinical and Rehabilitative Medicine and military Infectious Disease Research Programs.  Applications to place abstracts in focus area sessions will be accepted from January 17 to March 8, with acceptances notified by May 8.  The location and date of the 2017 MHSRS is still to be determined; the 2016 Symposium was held in Florida in August 2016.

 

This is such a significant opportunity we will be focusing Virginia Bio’s February Webinar, Thursday Feb. 23, 2017 on the MHSRS – what it is, what it can be for you, what they’re looking for in abstracts, how to make the most of your time at the Symposium, and how to weave it into your business development strategy.

 

Of course, we will continue to bring enhanced attention to more well-known sources of non-dilutive federal funding for the biosciences, such as the SBIR program at the National Institutes of Health.  Our friend, Rob Brooke at CIT, puts on a solid series of webinars and workshops across the state training companies and university researchers how better to access NIH funding.  As you will see on our Calendar of events, some are coming up soon:  on January 26 a webinar on SBIR, and on February 21 an NIH Proposal Prep Workshop in Charlottesville.  By the way, Rob just was recognized for his years of outstanding and tireless work by being named a 2016 Tibbets Award Winner for unique contributions to the SBIR program. Congratulations to Rob, and thanks our colleagues at CIT for their efforts on behalf of the Commonwealth.

 

Best regards,

 

 

 

Jeff Gallagher

Tags:  #jpmorganhealthcare # thriveinrva #biotech #g2gcon 

Share |
Permalink | Comments (0)
 

Our Premium Partners

Sign up for our newsletter
800 E. Leigh St.  |  Richmond, Va 23219-1534  |  PH: 804.643.6360  |  Email Us
Stay Connected